Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:39 pm Sale |
2021-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
ORBIMED ADVISORS LLC | 0 0.000% |
-1,040,825 (Position Closed) |
Filing History |
| 2021-05-17 4:35 pm Sale |
2021-05-17 | 13G | PANDION THERAPEUTICS INC PAND |
RA Capital Management, L.P. | 0 0.000% |
-1,770,023 (Position Closed) |
Filing History |
| 2021-04-08 5:24 pm Sale |
2021-04-01 | 13D | PANDION THERAPEUTICS INC PAND |
GLAXOSMITHKLINE PLC | 0 0.000% |
-2,262,301 (Position Closed) |
Filing History |
| 2021-04-02 09:54 am Sale |
2021-04-01 | 13D | PANDION THERAPEUTICS INC PAND |
AI Pan LLC | 0 0.000% |
-2,827,883 (Position Closed) |
Filing History |
| 2021-03-04 4:48 pm Purchase |
2021-02-24 | 13D | PANDION THERAPEUTICS INC PAND |
AI Pan LLC | 2,827,883 9.600% |
2,827,883 (New Position) |
Filing History |
| 2021-03-04 06:06 am Purchase |
2021-02-24 | 13D | PANDION THERAPEUTICS INC PAND |
Merck & Co. Inc. MRK |
11,776,706 39.990% |
11,776,706 (New Position) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
RA Capital Management, L.P. | 1,770,023 6.000% |
1,770,023 (New Position) |
Filing History |
| 2021-02-16 07:02 am Purchase |
2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
Roche Finance Ltd | 3,086,084 10.500% |
3,086,084 (New Position) |
Filing History |
| 2021-02-16 06:20 am Purchase |
2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
Access Industries Holdings LLC | 2,827,883 9.600% |
227,110 (+8.73%) |
Filing History |
| 2021-02-12 5:16 pm Purchase |
2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND |
Polaris Partners VIII L.P. | 3,201,422 12.700% |
3,201,422 (New Position) |
Filing History |
| 2020-07-31 5:39 pm Purchase |
2020-07-21 | 13D | PANDION THERAPEUTICS INC PAND |
GLAXOSMITHKLINE PLC | 2,262,301 7.900% |
2,262,301 (New Position) |
Filing History |
| 2020-07-31 4:26 pm Purchase |
2020-07-21 | 13G | PANDION THERAPEUTICS INC PAND |
Versant Venture Capital VI, L.P. | 3,176,507 11.100% |
3,176,507 (New Position) |
Filing History |
| 2020-07-29 9:05 pm Purchase |
2020-07-21 | 13D | PANDION THERAPEUTICS INC PAND |
Boxer Capital LLC | 2,107,513 7.400% |
2,107,513 (New Position) |
Filing History |
| 2020-07-27 5:57 pm Purchase |
2020-07-17 | 13G | PANDION THERAPEUTICS INC PAND |
ORBIMED ADVISORS LLC | 1,040,825 3.600% |
1,040,825 (New Position) |
Filing History |
| 2020-07-24 5:19 pm Purchase |
2020-07-21 | 13G | PANDION THERAPEUTICS INC PAND |
Access Industries Holdings LLC | 2,600,773 9.100% |
2,600,773 (New Position) |
Filing History |